Ulcerative Colitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Sulfate-reducing bacteria (SRB) are often isolated from animals and people with ulcerative colitis and can be involved in the IBD development in the gut-intestine axis.
|
31614543 |
2019 |
Ulcerative Colitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Change in paradigm: impact of an IBD medical home on the outpatient management of acute severe ulcerative colitis.
|
31586953 |
2019 |
Ulcerative Colitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Breast milk specimens from HC [n = 17] and IBD [n = 31 for Crohn's disease [CD]; and n = 41 for ulcerative colitis [UC]; were collected at 3 and 6 months postpartum [PP3] and [PP6], respectively.Faecal samples were also collected.
|
30418545 |
2019 |
Ulcerative Colitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
We used the University of Manitoba IBD Database to identify all persons in a Canadian province with CD or UC who received anti-TNF therapy between 2004 and 2016.
|
31211836 |
2019 |
Ulcerative Colitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Electronic databases (MEDLINE, EMBASE/EMBASE classic Cochrane CENTRAL register of controlled trials, the Cochrane IBD Group Specialised Trials Register and Clinicaltrials.gov registry) will be searched to identify all randomised placebo-controlled clinical trials of food and drug administration (FDA)-approved biologics for CD and UC (by March 2016).
|
30782731 |
2019 |
Ulcerative Colitis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In both, CD and UC, female gender and younger age at IBD diagnosis were significantly associated with extraintestinal skin manifestations.
|
30682031 |
2019 |
Ulcerative Colitis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The detection of the cytomegalovirus DNA in the colonic mucosa of patients with ulcerative colitis is associated with increased long-term risk of proctocolectomy: results from an outpatient IBD clinic.
|
30506156 |
2019 |
Ulcerative Colitis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A total of 51 patients with a modified Ulcerative Colitis Disease Activity Index (UCDAI) score of ≥4 and ≤10, and a modified UCDAI endoscopy subscore ≥1 were randomized for 6 weeks of double-blind treatment with IBD98 0.8 g/day or IBD 1.2 g/day or placebo.
|
31151306 |
2019 |
Ulcerative Colitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Earlier studies on antibiotics exposure and development of IBD (Crohn's disease (CD) and ulcerative colitis (UC)) may have been biased by familial factors and gastroenteritis.
|
29321166 |
2019 |
Ulcerative Colitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
In the past 5 years, the profiling of genome-wide gene expression, epigenomic features and gut microbiota composition in intestinal tissue and faecal samples has uncovered distinct molecular signatures that define IBD subtypes, including within Crohn's disease and ulcerative colitis.
|
30787446 |
2019 |
Ulcerative Colitis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Evidence-based inpatient ulcerative colitis management may be optimized with standardized algorithms that reinforce core principles, reduce care variation, and do not require IBD specialists to implement.
|
30980712 |
2019 |
Ulcerative Colitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Crohn's disease and ulcerative colitis, collectively known as IBD, are chronic inflammatory disorders of the gastrointestinal tract.
|
29789682 |
2018 |
Ulcerative Colitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Clinical efficacy and safety of golimumab in biologically experienced and naive patients with active ulcerative colitis: A real-life experience from two Italian IBD centers.
|
30039533 |
2018 |
Ulcerative Colitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
In a nationwide cohort study we identified 4695 children [< 18 years] diagnosed with incident IBD in 2002-2014 through the Swedish Patient Register [ulcerative colitis: n = 2295; Crohn's disease: n = 2174; inflammatory bowel disease-unclassified: n = 226].
|
29029152 |
2018 |
Ulcerative Colitis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Crohn's disease and ulcerative colitis are the most common forms of inflammatory bowel disease [IBD], affecting 1 in 250 of the population in the UK.
|
30445450 |
2018 |
Ulcerative Colitis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The corresponding values for acetaminophen use were (1.40, 95% CI, 0.96-2.04), I<sup>2</sup> = 45.6% for UC, and (1.56, 95% CI, 1.22-1.99), I<sup>2</sup> = 0.0% for IBD.
|
29620794 |
2018 |
Ulcerative Colitis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort Study.
|
29617750 |
2018 |
Ulcerative Colitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
This study was conducted at three IBD centers to determine factors affecting the efficacy of GMA in patients with moderately-to-severely active UC.
|
29977035 |
2018 |
Ulcerative Colitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Irritable Bowel Syndrome (IBS) shares overlapping symptoms and some features of pathogenesis with Inflammatory Bowel Diseases (IBD: Crohn's disease [CD], and Ulcerative Colitis [UC]).
|
29317064 |
2018 |
Ulcerative Colitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Increased knowledge of pathways involved in the pathogenesis of IBD has led to the development of new treatment options for Crohn's disease (CD) and ulcerative colitis (UC).
|
29430672 |
2018 |
Ulcerative Colitis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In patients with ulcerative colitis (UC) or Crohn's disease (CD), proton pump inhibitors have been associated with an increased risk for IBD flares and impaired outcomes.
|
29603881 |
2018 |
Ulcerative Colitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Ulcerative colitis [UC] is a chronic inflammatory disease that effects the gastrointestinal tract and is considered one of the most prominent and common forms of inflammatory bowel disease [IBD].
|
29040430 |
2018 |
Ulcerative Colitis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
From our IBD database, we identified 128 patients who underwent elective or urgent colectomy with the preoperative diagnosis of UC.
|
29282640 |
2018 |
Ulcerative Colitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
There were 3312 persons diagnosed with IBD (1480 CD, 1832 ulcerative colitis (UC)) in the study period.
|
29925912 |
2018 |
Ulcerative Colitis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Genotyping of the two variants, p.S361L and p.R801H, in IBD cases and controls showed that the p.S361L variant was significantly associated with an increased risk of ulcerative colitis [odds ratio 4.79, p = 0.0039] and IBD [odds ratio 3.17, p = 0.037].
|
29211899 |
2018 |